Atlas Trials

24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective, Open Study of 3 Months Duration.

Clinical trial NCT05299593 · UNKNOWN

Trial details

NCT number
NCT05299593
Sponsor
Fondazione G.B. Bietti, IRCCS
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Glaucoma, Open-AngleOcular Hypertension
Start date
2020-06-04
Primary completion
2022-06-30
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.